Global Agricultural Biologicals Market

1 INTRODUCTION OF GLOBAL AGRICULTURAL BIOLOGICALS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL AGRICULTURAL BIOLOGICALS MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL AGRICULTURAL BIOLOGICALS MARKET, BY PRODUCT
5.1 Overview
5.2 Biopesticides
5.3 Biofertilizers
5.4 Biostimulants
5.5 Others

6 GLOBAL AGRICULTURAL BIOLOGICALS MARKET, BY APPLICATION
6.1 Overview
6.2 Pulses and Oilseeds
6.3 Vegetables and Fruits
6.4 Grains and Cereals
6.5 Others

7 GLOBAL AGRICULTURAL BIOLOGICALS MARKET, BY SOURCE
7.1 Overview
7.2 Biorationals
7.3 Microbials
7.4 Others

8 GLOBAL AGRICULTURAL BIOLOGICALS MARKET, BY MODE OF APPLICATION
8.1 Overview
8.2 Seed Treatment
8.3 Foliar Spray
8.4 Seed Treatment

9 GLOBAL AGRICULTURAL BIOLOGICALS MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL AGRICULTURAL BIOLOGICALS MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Syngenta
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Koppert BV
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 DOW Chemical Company
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Certis USA
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Bayer Cropscience
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 ArystaLifescience Limited
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 BASF SE
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Marrone Bio Innovation Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Isagro Spa
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Development

11.10 T.Stanes and Company Limited
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Development

11.11 Novozymes A/S
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Development

12 Appendix
12.1 Related Reports